Differentiation of stem-like CD4 + T cells modulates early effector responses in colorectal cancer
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
In pMMR CRC mouse models, combined OX40 agonist and PD-1 blockade suppressed tumor progression by expanding Il7r + early effector CD4 + intermediates in tumor-draining lymph nodes, promoting migration and connection with T H 1-like cells.
Appeared: Saturday, November 14. Science. Peer-reviewed journal.